Multiple drugsPost-transplant lymphoproliferative disorder due to Epstein-Barr virus infection, and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2035卷 / 1期

关键词：

D O I：

10.1007/s40278-024-71113-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：363 / 363

相关论文

共 50 条

[1] Multiple drugsPost-transplant Epstein-Barr virus-associated lymphoproliferative disorder: case report
Reactions Weekly, 2018, 1703 (1) : 191 - 191
[2] Multiple drugsPost transplant Epstein Barr virus-related lymphoproliferative disorder and lack of efficacy: case report
Reactions Weekly, 2020, 1835 (1) : 279 - 279
[3] Multiple drugsPost transplant lymphoproliferative disorder and Epstein-Barr virus infection: 4 case reports
Reactions Weekly, 2021, 1865 (1) : 307 - 307
[4] Immunosuppressants/doxorubicinPost transplant lymphoproliferative disorder due to Epstein-Barr virus infection: case report
Reactions Weekly, 2017, 1656 (1) : 264 - 264
[5] Multiple drugsPost-transplant lymphoproliferative disorder: 2 case reports
Reactions Weekly, 2018, 1703 (1) : 192 - 192
[6] Mycophenolate/tacrolimus/valganciclovirPost-transplant lymphoproliferative disorder with associated Epstein-Barr virus infection; lack of efficacy: case report
Reactions Weekly, 2021, 1884 (1) : 328 - 328
[7] Multiple drugsPost-transplant lymphoproliferative disorder in the form of diffuse large B-cell lymphoma and lack of efficacy: case report
Reactions Weekly, 2023, 1979 (1) : 325 - 325
[8] Multiple drugsPost-transplant lymphoproliferative disorder and nephrotoxicity: 9 case reports
Reactions Weekly, 2021, 1868 (1) : 302 - 303
[9] Multiple drugsPost transplant lymphoproliferative disease and lack of efficacy: case report
Reactions Weekly, 2023, 1965 (1) : 352 - 352
[10] Antithymocyte-globulinPost-transplant lymphoproliferative disorder and Epstein-Barr virus infection: case report
Reactions Weekly, 2020, 1821 (1) : 43 - 43

← 1 2 3 4 5 →